top of page
Search

AI breast cancer diagnosis technology approved for UK and EU

  • Nov 16, 2021
  • 1 min read

The breast cancer diagnosis technology – called PANProfiler – has been developed by Panakeia and can accurately predict biomarker status from digitally imaged routine pathology samples. The technology has received UKCA and CE certification for clinical use by health services in the UK and EU. Read more



 
 
 

Comments


panakeia.png
panakeia word logo only.png

Next generation Multi-omics and Biomarker Profiling

About

Panakeia Technologies LTD
Salisbury House, Station Road
Cambridge, England, CB1 2LA
Registration no 11696687

Privacy Policy >

Regulatory Note

Unless otherwise stated all products are intended for Research Use Only, not for use in diagnostic procedures.

Social

  • White Twitter Icon
  • White LinkedIn Icon

© 2024 Panakeia Technologies

bottom of page